Tu sei qui: Home > Cannabinoids (precedente) > Letter: Preclinical assessment of abuse liability of ajulemic acid

Cannabinoids 2007;2(1):3-4 (21 January 2007)

Letter to the Editor

Letter: Preclinical assessment of abuse liability of ajulemic acid

Jenny L. Wiley

Department of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, VA, USA, jwiley@vcu.edu

No abstract available.

[ PDF del testo completo ]

Eventi online 2020

Tutte le informazioni sugli eventi online dell'IACM, compresi i video gratuiti dei webinar con sottotitoli in italiano, si possono trovare qui.

Conferenza IACM 2022

La 12a Conferenza IACM sui cannabinoidi in medicina si terrà il 20 e 21 ottobre 2022 insieme alla SSCM svizzera a Basilea/Svizzera.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.